Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-15

Clinical Trial Update: Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating a noise-augmented automatic speech recognition-based speech treatment for Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Teachers College, Columbia University | Conditions: Parkinson Disease | EARLY_Phase 1 | Status: RECRUITING